Global Irritable Bowel Syndrome (IBS) Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
132
Industry
Drugs by Therapeutic Area
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.

The global Irritable Bowel Syndrome (IBS) market size was estimated at USD 6252.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Irritable Bowel Syndrome (IBS) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Irritable Bowel Syndrome (IBS) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Irritable Bowel Syndrome (IBS) market.
Global Irritable Bowel Syndrome (IBS) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals

Market Segmentation (by Type)
IBS-D Drug
IBS-C Drug
Others

Market Segmentation (by Application)
Women
Men

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Irritable Bowel Syndrome (IBS) Market
Overview of the regional outlook of the Irritable Bowel Syndrome (IBS) Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Irritable Bowel Syndrome (IBS) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Irritable Bowel Syndrome (IBS), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Irritable Bowel Syndrome (IBS)
    • 1.2 Key Market Segments
      • 1.2.1 Irritable Bowel Syndrome (IBS) Segment by Type
      • 1.2.2 Irritable Bowel Syndrome (IBS) Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Irritable Bowel Syndrome (IBS) Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Irritable Bowel Syndrome (IBS) Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Irritable Bowel Syndrome (IBS) Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Irritable Bowel Syndrome (IBS) Product Life Cycle
    • 3.3 Global Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2020-2025)
    • 3.4 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Irritable Bowel Syndrome (IBS) Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Irritable Bowel Syndrome (IBS) Market Competitive Situation and Trends
      • 3.8.1 Irritable Bowel Syndrome (IBS) Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Irritable Bowel Syndrome (IBS) Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Irritable Bowel Syndrome (IBS) Industry Chain Analysis
    • 4.1 Irritable Bowel Syndrome (IBS) Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Irritable Bowel Syndrome (IBS) Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Irritable Bowel Syndrome (IBS) Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy ? April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Irritable Bowel Syndrome (IBS) Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Irritable Bowel Syndrome (IBS) Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2020-2025)
    • 6.3 Global Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
    • 6.4 Global Irritable Bowel Syndrome (IBS) Price by Type (2020-2025)
  • 7 Irritable Bowel Syndrome (IBS) Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Irritable Bowel Syndrome (IBS) Market Sales by Application (2020-2025)
    • 7.3 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2020-2025)
  • 8 Irritable Bowel Syndrome (IBS) Market Sales by Region
    • 8.1 Global Irritable Bowel Syndrome (IBS) Sales by Region
      • 8.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Region
      • 8.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region
    • 8.2 Global Irritable Bowel Syndrome (IBS) Market Size by Region
      • 8.2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region
      • 8.2.2 Global Irritable Bowel Syndrome (IBS) Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Irritable Bowel Syndrome (IBS) Sales by Country
      • 8.3.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Irritable Bowel Syndrome (IBS) Sales by Country
      • 8.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region
      • 8.5.2 Asia Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Irritable Bowel Syndrome (IBS) Sales by Country
      • 8.6.2 South America Irritable Bowel Syndrome (IBS) Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Region
      • 8.7.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Irritable Bowel Syndrome (IBS) Market Production by Region
    • 9.1 Global Production of Irritable Bowel Syndrome (IBS) by Region(2020-2025)
    • 9.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2020-2025)
    • 9.3 Global Irritable Bowel Syndrome (IBS) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Irritable Bowel Syndrome (IBS) Production
      • 9.4.1 North America Irritable Bowel Syndrome (IBS) Production Growth Rate (2020-2025)
      • 9.4.2 North America Irritable Bowel Syndrome (IBS) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Irritable Bowel Syndrome (IBS) Production
      • 9.5.1 Europe Irritable Bowel Syndrome (IBS) Production Growth Rate (2020-2025)
      • 9.5.2 Europe Irritable Bowel Syndrome (IBS) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Irritable Bowel Syndrome (IBS) Production (2020-2025)
      • 9.6.1 Japan Irritable Bowel Syndrome (IBS) Production Growth Rate (2020-2025)
      • 9.6.2 Japan Irritable Bowel Syndrome (IBS) Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Irritable Bowel Syndrome (IBS) Production (2020-2025)
      • 9.7.1 China Irritable Bowel Syndrome (IBS) Production Growth Rate (2020-2025)
      • 9.7.2 China Irritable Bowel Syndrome (IBS) Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Bausch Health
      • 10.1.1 Bausch Health Basic Information
      • 10.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Overview
      • 10.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Product Market Performance
      • 10.1.4 Bausch Health Business Overview
      • 10.1.5 Bausch Health SWOT Analysis
      • 10.1.6 Bausch Health Recent Developments
    • 10.2 Allergan
      • 10.2.1 Allergan Basic Information
      • 10.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Overview
      • 10.2.3 Allergan Irritable Bowel Syndrome (IBS) Product Market Performance
      • 10.2.4 Allergan Business Overview
      • 10.2.5 Allergan SWOT Analysis
      • 10.2.6 Allergan Recent Developments
    • 10.3 Takeda
      • 10.3.1 Takeda Basic Information
      • 10.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Overview
      • 10.3.3 Takeda Irritable Bowel Syndrome (IBS) Product Market Performance
      • 10.3.4 Takeda Business Overview
      • 10.3.5 Takeda SWOT Analysis
      • 10.3.6 Takeda Recent Developments
    • 10.4 Sucampo Pharmaceuticals (Mallinckrodt)
      • 10.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Basic Information
      • 10.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Overview
      • 10.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Market Performance
      • 10.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
      • 10.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
    • 10.5 Sebela Pharmaceuticals Inc
      • 10.5.1 Sebela Pharmaceuticals Inc Basic Information
      • 10.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Overview
      • 10.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Market Performance
      • 10.5.4 Sebela Pharmaceuticals Inc Business Overview
      • 10.5.5 Sebela Pharmaceuticals Inc Recent Developments
    • 10.6 Astellas Pharmaceuticals
      • 10.6.1 Astellas Pharmaceuticals Basic Information
      • 10.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Overview
      • 10.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Market Performance
      • 10.6.4 Astellas Pharmaceuticals Business Overview
      • 10.6.5 Astellas Pharmaceuticals Recent Developments
  • 11 Irritable Bowel Syndrome (IBS) Market Forecast by Region
    • 11.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast
    • 11.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country
      • 11.2.3 Asia Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Region
      • 11.2.4 South America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Irritable Bowel Syndrome (IBS) by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Irritable Bowel Syndrome (IBS) Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Irritable Bowel Syndrome (IBS) by Type (2026-2035)
      • 12.1.2 Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Irritable Bowel Syndrome (IBS) by Type (2026-2035)
    • 12.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Application (2026-2035)
      • 12.2.1 Global Irritable Bowel Syndrome (IBS) Sales (K MT) Forecast by Application
      • 12.2.2 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.